Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study.

Lombardi, Giuseppe; Caccese, Mario; Padovan, Marta; Cerretti, Giulia; Pintacuda, Giovanna; Manara, Renzo; Di Sarra, Francesca; Zagonel, Vittorina

Lombardi, Giuseppe; Caccese, Mario; Padovan, Marta; Cerretti, Giulia; Pintacuda, Giovanna; Manara, Renzo; Di Sarra, Francesca; Zagonel, Vittorina.

Afiliação

Lombardi G; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, via Gattamelata 64, 35128 Padua, Italy.
Caccese M; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, via Gattamelata 64, 35128 Padua, Italy.
Padovan M; Clinical and Experimental Oncology and Immunology PhD Program, Department of Surgery, Oncology and Gastroenterology, University of Padua, 35128 Padua, Italy.
Cerretti G; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, via Gattamelata 64, 35128 Padua, Italy.
Pintacuda G; Clinical and Experimental Oncology and Immunology PhD Program, Department of Surgery, Oncology and Gastroenterology, University of Padua, 35128 Padua, Italy.
Manara R; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, via Gattamelata 64, 35128 Padua, Italy.
Di Sarra F; Radiology Unit, Veneto Institute of Oncology IOV-IRCCS, via Gattamelata 64, 35128 Padua, Italy.
Zagonel V; Department of Neurosciences, Neuroradiology Unit, University of Padua, 35128 Padua, Italy.

Cancers (Basel) ; 13(18)2021 Sep 21.

Article em En | MEDLINE | ID: mdl-34572958

Palavras-chave

brain tumors; glioblastoma; glioma; regorafenib; targeted therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google